Literature DB >> 6204066

Analysis of presenting symptoms in prostatism.

P C Frimodt-Møller, K M Jensen, P Iversen, P O Madsen, R C Bruskewitz.   

Abstract

A prospective evaluation was done of 84 patients who were selected for transurethral prostatectomy based on the presenting symptoms and findings at cystoscopy. In addition, urodynamic studies were performed but the results were not made available to the urologist who selected the patients for surgery. Postoperative symptom analysis and repeat urodynamic examinations were done at 3 months in 68 patients and at 12 months in 50. There was no significant association between irritative symptoms and uninhibited detrusor contractions. Furthermore, no associations were identified between obstructive symptoms and infravesical obstruction as defined by urodynamic criteria. The study failed to identify a need for routine invasive urodynamic investigation of patients with benign prostatic hypertrophy.

Entities:  

Mesh:

Year:  1984        PMID: 6204066     DOI: 10.1016/s0022-5347(17)49587-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

Review 1.  Benign prostatic hyperplasia and its treatment.

Authors:  J B Stimson; S D Fihn
Journal:  J Gen Intern Med       Date:  1990 Mar-Apr       Impact factor: 5.128

2.  [Diagnostic and differential diagnosis of benign prostate syndrome (BPS): guidelines of the German Urologists].

Authors:  R Berges; K Dreikorn; K Höfner; S Madersbacher; M C Michel; R Muschter; M Oelke; O Reich; W Rulf; C Tschuschke; U Tunn
Journal:  Urologe A       Date:  2009-11       Impact factor: 0.639

3.  The significance of age on symptoms and urodynamic- and cystoscopic findings in benign prostatic hypertrophy.

Authors:  O Simonsen; B Møller-Madsen; T Dørflinger; J P Nørgåard; H S Jørgensen; E Lundhus
Journal:  Urol Res       Date:  1987

4.  Using health-related quality-of-life information: clinical encounters, clinical trials, and health policy.

Authors:  J Tsevat; J C Weeks; E Guadagnoli; A N Tosteson; C M Mangione; J S Pliskin; M C Weinstein; P D Cleary
Journal:  J Gen Intern Med       Date:  1994-10       Impact factor: 5.128

5.  Correlation of quality of life with clinical symptoms and signs at the time of glaucoma diagnosis.

Authors:  R P Mills
Journal:  Trans Am Ophthalmol Soc       Date:  1998

6.  Outcome of elective prostatectomy.

Authors:  D E Neal; P D Ramsden; L Sharples; A Smith; P H Powell; R A Styles; R J Webb
Journal:  BMJ       Date:  1989-09-23

Review 7.  Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia.

Authors:  M I Wilde; A Fitton; E M Sorkin
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

Review 8.  Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia.

Authors:  M I Wilde; A Fitton; D McTavish
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

9.  Depressive symptoms and health-related quality of life: the Heart and Soul Study.

Authors:  Bernice Ruo; John S Rumsfeld; Mark A Hlatky; Haiying Liu; Warren S Browner; Mary A Whooley
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

10.  Self-efficacy and health status in patients with coronary heart disease: findings from the heart and soul study.

Authors:  Urmimala Sarkar; Sadia Ali; Mary A Whooley
Journal:  Psychosom Med       Date:  2007-05-17       Impact factor: 4.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.